Pietro Napodano Selected Research

Pietro Napodano Research Topics

5	Proteinuria 02/2016 - 11/2002
4	Membranous Glomerulonephritis (Membranous Nephropathy) 02/2016 - 07/2002
4	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2013 - 07/2002
4	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2013 - 07/2002
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2013 - 02/2003
3	Glomerulonephritis 07/2010 - 07/2002
3	IGA Glomerulonephritis (IGA Nephropathy) 05/2009 - 07/2002
2	Sclerosis 05/2009 - 02/2003
1	Calciphylaxis 06/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Hyponatremia 01/2022
1	Chronic Renal Insufficiency 01/2021
1	Nephritis 06/2020
1	Lupus Nephritis 06/2020
1	Hypertension (High Blood Pressure) 06/2020
1	Thrombotic Microangiopathies 07/2010
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 11/2002

6	Immunoglobulin G (IgG)IBA 01/2013 - 11/2002
4	Proteins (Proteins, Gene)FDA Link 01/2013 - 02/2003
4	CreatinineIBA 05/2009 - 11/2002
3	SteroidsIBA 01/2021 - 02/2003
2	AntibodiesIBA 02/2016 - 07/2002
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2013 - 02/2003
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2012 - 05/2009
1	coumarinIBA 06/2022
1	AnticoagulantsIBA 06/2022
1	nasIBA 06/2020
1	Serum AlbuminIBA 02/2016
1	Phospholipase A2 ReceptorsIBA 02/2016
1	AutoantibodiesIBA 02/2016
1	Antiphospholipid AntibodiesIBA 07/2010
1	Pregnancy-Associated alpha 2-Macroglobulins (alpha 2 Macroglobulin)IBA 05/2009
1	MicropeptidesIBA 11/2002
1	Hexosaminidases (Hexosaminidase)IBA 11/2002
1	LDL Lipoproteins (beta Lipoproteins)IBA 07/2002
1	Immunoglobulin A (IgA)IBA 07/2002
1	oxidized low density lipoproteinIBA 07/2002
1	low density lipoprotein inhibitorIBA 07/2002

3	Therapeutics 01/2021 - 02/2003
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2022